Case report: PRES associated with fruquintinib in a patient with metastatic colon cancer

Posterior reversible encephalopathy syndrome (PRES) is a rare, reversible neurological disease that is frequently associated with the use of targeted therapy agents. In this case study, we examine the development of posterior reversible encephalopathy syndrome (PRES) in a 44-year-old woman with meta...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Lu, Zeng, Zhaohao, Wu, Zhiqiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10570160/
https://www.ncbi.nlm.nih.gov/pubmed/37581770
http://dx.doi.org/10.1007/s10072-023-06991-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10570160/
https://www.ncbi.nlm.nih.gov/pubmed/37581770
http://dx.doi.org/10.1007/s10072-023-06991-7

Ejemplares similares